CN105011165A - 一种改善由高血压引起的心脏病的养生粥 - Google Patents
一种改善由高血压引起的心脏病的养生粥 Download PDFInfo
- Publication number
- CN105011165A CN105011165A CN201510453493.9A CN201510453493A CN105011165A CN 105011165 A CN105011165 A CN 105011165A CN 201510453493 A CN201510453493 A CN 201510453493A CN 105011165 A CN105011165 A CN 105011165A
- Authority
- CN
- China
- Prior art keywords
- parts
- celery
- water
- chrysanthemum
- consumption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 56
- 235000021395 porridge Nutrition 0.000 title claims abstract description 47
- 208000019622 heart disease Diseases 0.000 title claims abstract description 16
- 240000007087 Apium graveolens Species 0.000 claims abstract description 49
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims abstract description 49
- 235000010591 Appio Nutrition 0.000 claims abstract description 49
- 241000931705 Cicada Species 0.000 claims abstract description 37
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 33
- 240000008042 Zea mays Species 0.000 claims abstract description 32
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 32
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 32
- 235000005822 corn Nutrition 0.000 claims abstract description 32
- 235000012907 honey Nutrition 0.000 claims abstract description 31
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 244000302512 Momordica charantia Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- 230000000694 effects Effects 0.000 claims description 34
- 238000002360 preparation method Methods 0.000 claims description 25
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 24
- 235000018365 Momordica dioica Nutrition 0.000 claims description 24
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 22
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 20
- 240000000171 Crataegus monogyna Species 0.000 claims description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 20
- 230000003130 cardiopathic effect Effects 0.000 claims description 19
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims description 18
- 241000132536 Cirsium Species 0.000 claims description 18
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 18
- 244000247747 Coptis groenlandica Species 0.000 claims description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 241000212321 Levisticum Species 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 235000013339 cereals Nutrition 0.000 claims description 7
- 230000035613 defoliation Effects 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 238000010257 thawing Methods 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 241000723353 Chrysanthemum Species 0.000 claims 6
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 26
- 239000003814 drug Substances 0.000 abstract description 20
- 235000013305 food Nutrition 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 230000036461 convulsion Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000729173 Cirsium japonicum Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 230000004531 blood pressure lowering effect Effects 0.000 abstract 1
- 230000003684 cardiac depression Effects 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 30
- 208000024891 symptom Diseases 0.000 description 24
- 240000001740 Momordica dioica Species 0.000 description 22
- 230000001631 hypertensive effect Effects 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000000747 cardiac effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 210000005240 left ventricle Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000819999 Nymphes Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 244000179560 Prunella vulgaris Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000001447 compensatory effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000008113 selfheal Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010024119 Left ventricular failure Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229930185803 charantin Natural products 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001029 Acute pulmonary oedema Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- JXRNMQDTJAQLAQ-UTZXOHNXSA-N Aplotaxene Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCC=C JXRNMQDTJAQLAQ-UTZXOHNXSA-N 0.000 description 1
- ZFSOYHNWYLNZIP-UHFFFAOYSA-N Aplotaxene Natural products CCC=CCC=CC=CCCCCCCC=C ZFSOYHNWYLNZIP-UHFFFAOYSA-N 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000002848 Cyperus flabelliformis Nutrition 0.000 description 1
- 240000001505 Cyperus odoratus Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- JXRNMQDTJAQLAQ-UHFFFAOYSA-N Heptadecatetraen Natural products CCC=CCC=CCC=CCCCCCC=C JXRNMQDTJAQLAQ-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- BAHUBXAYVOCLNA-UHFFFAOYSA-N Isoangelol Natural products O1C(=O)C=CC2=C1C=C(OC)C(C(OC(=O)C(C)=CC)C(O)C(C)(C)O)=C2 BAHUBXAYVOCLNA-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 235000009199 Lamium album Nutrition 0.000 description 1
- 244000303199 Lamium album Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241000521581 Millettia Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 235000000365 Oenanthe javanica Nutrition 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000004327 Paroxysmal Dyspnea Diseases 0.000 description 1
- DUXQKCCELUKXOE-UHFFFAOYSA-N Pectolinarigenin-Biosid Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(C)O2)O)O1 DUXQKCCELUKXOE-UHFFFAOYSA-N 0.000 description 1
- SEXCCMQJDXQBOE-UHFFFAOYSA-N Pectolinarin Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(OC2C(C(O)C(O)C(C)O2)O)C(CO)O1 SEXCCMQJDXQBOE-UHFFFAOYSA-N 0.000 description 1
- 235000002770 Petroselinum crispum Nutrition 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 235000005010 Scirpus paludosus Nutrition 0.000 description 1
- 244000058416 Scirpus paludosus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229930183733 angelol Natural products 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- -1 carrotene Proteins 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000848 glutamatergic effect Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 244000138993 panchioli Species 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- DUXQKCCELUKXOE-CBBZIXHGSA-N pectolinarin Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 DUXQKCCELUKXOE-CBBZIXHGSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Insects & Arthropods (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成:山楂18份,西红花1.5份,苦瓜粉10份,芹菜35份,玉米180份,蝉蜕9份,泽泻5份,黄连9份,当归9份,菊花7份,独活10份,大蓟12份,蜂蜜22份。本发明中药组合物符合中医改善由高血压引起的心脏病的原理。选用的药材有降低血压的功效,并且药材与食物搭配,且能舒缓心郁气结、促进血液循环、安神定惊,对高血压患者有极好的治疗作用,是目前治疗由高血压引起的心脏病较为理想的食物。
Description
分案申请,原申请号2014103236694,申请日2014.7.9,名称改善由高血压引起的心脏病的养生粥及其制备方法。
技术领域
本发明涉及中医中药领域,尤其是涉及一种改善由高血压引起的心脏病的养生粥及其制备方法。
背景技术
高血压性心脏病是由于血压长期升高使左心室负荷逐渐加重,左心室因代偿而逐渐肥厚和扩张而形成的器质性心脏病。高血压性心脏病一般出现在高血压病起病数年至十余年后,根据心功能变化情况可分为心功能代偿期和心功能失代偿期。在心功能代偿期,病人可无明显自觉症状,但在心功能失代偿期,则逐渐出现左心衰竭的症状,开始时仅在劳累、饱食或说话过多时感心悸、气喘、咳嗽,以后症状逐渐加重,上述症状呈阵发性发作,多表现为夜间阵发性呼吸困难并 痰中带血,严重时可发生急性肺水肿。
高血压病可分为原发性和继发性两种、各型高血压达到一定的时间和程度使左室负荷加重,继而发生左室肥厚、增大,均可称为高血压性心脏病。
高血压性心脏病早期表现一般不典型,病人可无明显自觉症状或仅有轻度不适如心悸、头痛等,这些症状主要是高血压的一般症状,无特殊性。随高血压病程的进展,病人逐渐出现早期在左心室向心性肥厚而无扩大阶段,血压升高、脉搏洪大、心尖搏动增强,主动脉瓣区第二心音亢进;在左心室扩大阶段,心尖搏动向左下移位,呈抬举样心尖搏动,心浊音界向左下扩大,心尖部第一心音增强,主动脉 瓣区第二心音呈高亢金属调;病程进一步发展,当左心室明显扩大,主动脉瓣亦发生粥样硬化病变时,主动脉瓣第二听诊区可闻及舒张期水波样杂音,可闻及第四心音及各种心律失常如心房纤颤、早搏等。
高血压时由于动脉血管压力过高,阻碍心脏泵出血液,心脏长期高负荷工作就出现了心肌肥厚和僵硬度增加,最终导致进入心脏的肺静脉血受阻,形成肺淤血。心肌肥大时需氧量增加,血液供应相对不足,常导致心衰发作。高血压性心脏病晚期临床表现为:
1、由于左心室舒张功能异常,可导致肺淤血,主要表现为:⑴出现疲劳、气喘、心悸、咳嗽、咯血等症状;⑵平卧时出现气急,坐起后即好转;⑶活动量不大,但出现呼吸困难,严重时患者可在睡梦中惊醒。2、左心衰竭常可累及右心室功能下降,形成全心衰竭,主要表现为:⑴紫绀;⑵颈静脉明显充盈;⑶右上腹疼痛,并有肝肿大;⑷双下肢浮肿,严重时可出现全身浮肿;⑸少尿,多出现于心衰失代偿期;⑹中老年人常出现脑血管疾病 。
在现有的改善由高血压引起的心脏病的药物中,授权公告号 CN 103055126 B(申请号 201310017155.1)的专利公开了一种治疗高血压性心脏病的中药组合物及其制备方法,一种治疗高血压性心脏病的中药组合物的制备方法,其特征在于,取下述重量配比的原料 :西洋参 1-5 份,黄芪 25-35 份,西红花 1-5 份,茯苓 15-35 份,天花粉 15-30 份,柏子仁5-12份,降香1-5份,麦冬5-15份,白芍25-35份,夏枯草8-15份,天然冰片0.3-0.9份,钩藤 9-15份。申请公布号 CN 102451267 A(申请号 201010537115.6)的专利一种治疗高血压性心脏病的中药,其特征在于它由附片、血藤、潞党参、甘草、莶草、生龙牡、枳壳、夏枯草、菊花子、甘草、葛根、金银花、珍珠母、黄芪组成;其重量份配比为:附片 5、鸡血藤 6-8、潞党参 6-8、炙甘草 6-8、稀莶草3-5、生龙牡 2-4、枳壳 4-6、夏枯草9-8、菊花子3-5、甘草2-3、葛根7-9、金银花6-8、珍珠母3-5、黄芪3-5。
发明内容
针对现有的治疗现状,本发明的目的之一在于提供一种改善由高血压引起的心脏病的养生粥,具有无痛苦、易操作、疗效显著、无副作用的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的另一目的就是提供上述养生粥的制备方法。
本发明的上述目的是通过以下技术方案来实现的:
改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成:山楂10-18份,西红花0.5-1.5份,苦瓜粉6-10份,芹菜25-35份,玉米70-180份,蝉蜕6-9份,泽泻1-5份,黄连6-9份,当归5-9份,菊花3-7份,独活5-10份,大蓟6-12份,蜂蜜16-22份。
改善由高血压引起的心脏病的养生粥,优选的方案在于:取下述重量配比的主要原料制备而成:山楂12-16份,西红花0.8-1.3份,苦瓜粉5-9份,芹菜28-33份,玉米100-150份,蝉蜕7-8份,泽泻2-4份,黄连7-8份,当归6-8份,菊花4-6份,独活7-9份,大蓟8-10份,蜂蜜18-20份。
改善由高血压引起的心脏病的养生粥,更佳优选的方案在于:取下述重量配比的主要原料制备而成:山楂14份,西红花1份,苦瓜粉7份,芹菜30份,玉米120份,蝉蜕7.5份,泽泻3份,黄连7.5份,当归7份,菊花5份,独活8份,大蓟9份,蜂蜜19份。
根据前面所述具有改善由高血压引起的心脏病功效的养生粥的制备方法,优选的方案在于:步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,榨1-3分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于70-90℃的热水中浸泡,浸泡至水温为30-40℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过80-120目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡1-3小时(优选浸泡2小时),武火煎开,转文火煎20-40分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1-3小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
根据前面所述的制备方法,优选的方案在于:步骤(1)水的用量是芹菜质量的1-5倍(优选的,水的用量是芹菜质量的2-4倍;更加优选的,水的用量是芹菜质量的3倍)。
根据前面所述的制备方法,优选的方案在于:步骤(2)水的用量是菊花和蝉蜕总用量的2-6倍(优选的,水的用量是菊花和蝉蜕总用量的3-5倍,更加优选的,水的用量是菊花和蝉蜕总用量的4倍)。
根据前面所述的制备方法,优选的方案在于:步骤(2)将菊花和蝉蜕置于75-85℃的热水中浸泡(优选置于80℃的热水中浸泡)。
根据前面所述的制备方法,优选的方案在于:步骤(2)浸泡至水温为33-38℃时过滤(优选浸泡至水温为35℃时过滤)。
根据前面所述的制备方法,优选的方案在于:步骤(3)玉米块过90-110目筛(优选过100目筛)。
根据前面所述的制备方法,优选的方案在于:步骤(5)小火熬制1.5-2.5小时后加入蜂蜜(小火熬制2小时后加入蜂蜜)。
使用方法:为使本发明达到最佳效果,制好的养生粥,每次取50g,与早晚饭同食。
各原料药的药理功效分别为:
山楂:山楂具有降血脂、血压、强心、抗心律不齐等作用,同时,山楂也是健脾开胃、消食化滞、活血化痰的良药。对胸膈脾满、疝气、血淤、闭经等症有很好的疗效。山楂内的黄酮类化合物牡荆素,是一种抗癌作用较强的药物,山楂提取物对癌细胞体内生长、增殖和浸润转移均有一定的抑制作用。
西红花:味甘,性平。有增强细胞内的氧代谢功能,提高心脏的耐缺氧能力,活血化瘀,凉血解毒的功效,对心脏有一定保护作用,且具有明显的抑癌抗癌的作用。
苦瓜粉:苦瓜粉由苦瓜经低温烘干超微粉碎而成,苦瓜粉含有丰富的含有蛋白质、脂肪、糖类、纤维素、胡萝卜素、维生素B2、维生素C、苦瓜苷、钙、铁、磷等。其中,维生素C含量非常丰富,苦瓜粉性寒味苦,具有清暑祛热、明目解毒、养血益气等功效,对热病烦渴、中暑、痢疾、目赤、痈肿丹毒、恶疮等有食疗作用。此外,苦瓜中含有的有效成份“植物胰岛素”,即苦瓜苷,能安全、平稳降低血糖,重要的是改善胰岛腺功能修复B细胞,对并发症有明显的改善作用,同时具有调节血脂、降低血压的作用,还能使胰岛素细胞活性增强,自身调节血糖的能力地增强,加速血糖氧化,符合人体代谢的自然规律。苦瓜另一个作用是清暑除烦、解,、明目、益气壮阳,平时吃苦瓜可以清毒,降火,并且苦瓜还有"植物胰岛素"的美誉,能够预防和改善糖尿病的并发症,具有调节血脂并提高免疫力的作用。
芹菜:芹菜,属伞形科植物。有水芹、旱芹两种,功能相近,药用以旱芹为佳。旱芹香气较浓,又名“香芹”,亦称"药芹"。富含蛋白质、碳水化合物、胡萝卜素、B族维生素、钙、磷、铁、钠等,同时,具有有平肝清热,祛风利湿,除烦消肿,凉血止血,解毒宣肺,健胃利血、清肠利便、润肺止咳、降低血压、健脑镇静的功效。常吃芹菜,尤其是吃芹菜叶,对预防血液粘稠度、动脉硬化等都十分有益,并有辅助治疗作用。
玉米:玉米营养丰富:含有碳水化合物:74.8克,蛋白质:29克,脂肪:16.6克,膳食纤维6.9克。可以说玉米是当之无愧的第一黄金主食”,营养专家称,玉米所含的“全能营养”适合各个年龄段的人群食用,其丰富的谷氨酸能促进大脑发育,是儿童最好的“益智食物”;所含维生素B族能调节神经,是适合白领的“减压食品”;富含的亚油酸、钙质,能帮助调脂、降压,高纤维含量则使玉米成为很好的“刮肠食物”,能预防中年发福;此外,玉米中富含的谷胱甘肽是最有效的抗癌成分,其所含丰富的维生素E也能帮助抗衰老,软化血管。具有利尿、降压、利胆、降血糖的功效。
蝉蜕:蝉蜕老熟若虫变化为成虫时,羽化蜕除的外壳称蝉蜕,又称“蝉退”或“蝉皮”,其主要成分含甲壳素及蛋白质,味甘、咸、寒,入肺、肝经,是重要的辛凉解表中药。蝉蜕作为传统中药成分,具有抗菌、祛寒、镇惊、利尿的功能。鲜嫩的蝉蜕若虫和成虫,特别是若虫不仅营养丰富、味道鲜美,药用价值也特别高,为药膳上品。
泽泻:性味: 甘,寒。归经: 归肾、膀胱经。功效: 利小便,清湿热。主治: 用于小便不利.水肿胀满,泄泻尿少,痰饮眩晕,热淋涩痛;高血脂。
黄连:功效清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。药理作用:1、抗菌作用 2、抗真菌作用 3、抗病毒作用 4、抗阿米巴作用 5、抗炎、抗腹泻作用 6.、对心血管作用7、解热作用 8、降血糖作用 9、降血脂作用 10、抗氧化作用 11、对血液系统的影响 12、抗溃疡作用。
当归:性味: 甘、辛,温。 归经: 归肝、心、脾经。功效: 补血活血,调经止痛,润肠通便。主治: 用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
菊花:性味: 甘、苦,微寒。归经: 归肺、肝经。功效: 散风清热,平肝明目。主治: 用于风热感冒,头痛眩晕,目赤肿痛,眼目昏花。
独活:为伞形科当归属植物重齿当归的根。成分:含香豆素类化合物,挥发油,乙酸酯,当归醇,百里香酚。药理:对心血管系统有很重要的作用,有降压的作用,能促进血小板的聚集,具有良好的镇痛和抗炎作用。具有抗光敏的作用,对抵抗肿瘤有显著的疗效,对抗菌消炎也有很重要的作用。药性:苦,微温,辛。归肾、膀胱经。功能主治:祛风胜湿,散寒止痛。
大蓟:又名马蓟、野刺菜、茨芥,为菊科蓟属植物大蓟的地上部分或根。药性:味甘,性微凉。成分:新鲜叶含有柳穿鱼苷;根含挥发油成分单紫杉烯,香附子烯,丁香烯。根据现代药理研究发现,该药具有止血、降压、抗菌、行瘀消肿的功效,用于吐血,咯血,衄血,便血,尿血,疮疡肿痛,肾炎,湿疹等。
蜂蜜:蜂蜜对某些慢性病还有一定的疗效。常服蜂蜜对于心脏病、血液粘稠度、肺病、眼病、肝脏病、痢疾、便秘、贫血、神经系统疾病、胃和十二指肠溃疡病等 都有良好的辅助医疗作用。外用还可以治疗烫伤、滋润皮肤和防治冻伤。
本发明养生粥符合中医治疗血液粘稠度的原理。选用的药材有改善由高血压引起的心脏病的功效,并且药材与食物搭配,且能舒缓心郁气结、促进血液循环、安神定惊,对血液粘稠度患者有极好的治疗作用,是目前是治疗血液粘稠度较为理想的食物。
与现有技术相比,本发明的技术优势还体现在:
本发明与现有技术相比较,其技术效果体现在:
(1)制备方法简单,提取效率高,能耗及损耗小,成本低;
(2)增加了营养成分和药效成分,但没有改变各原料制备的养生粥的风味。
(3)长期服用本品对改善由高血压引起的心脏病、肝功能障碍有特殊疗效,还能美容养颜,补脾养心。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1 改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成(每份取10g):山楂10份,西红花0.5份,苦瓜粉6份,芹菜25份,玉米70份,蝉蜕6份,泽泻1份,黄连6份,当归5份,菊花3份,独活5份,大蓟6份,蜂蜜16份。
改善由高血压引起的心脏病的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的1倍,榨1分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于70℃的热水中浸泡,浸泡至水温为30℃时,水的用量是菊花和蝉蜕总用量的2倍,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过80目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡1小时,武火煎开,转文火煎20分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
典型病例一:邹XX,男,42岁,山东省淄博市临淄区。症状:患者半月前开始出现咯血,心悸等症状,平卧时出现气急的症状,坐起后症状即有所好转,经医院了解,患者患有高血压,诊断其为高血压性心脏病。病龄:1个月。巩固10天,不适症状未再出现,使用期间无副作用。
服用实施例1所得养生粥,每次取50g,与早晚饭同食,使用当天2天,心悸症状减轻,使用5天,咯血次数减少,心悸消失,平卧时气急症状有所好转,继续服用实施例1所得养生粥10天,血压恢复正常,咯血症状消失,平卧时气急症状也消失了;一直以来患者服用实施例1所得养生粥,抵抗力增强,饭量也渐增,血压稳定。
实施例2 改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成(每份取15g):山楂18份,西红花1.5份,苦瓜粉10份,芹菜35份,玉米180份,蝉蜕9份,泽泻5份,黄连9份,当归9份,菊花7份,独活10份,大蓟12份,蜂蜜22份。
具有改善由高血压引起的心脏病功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的5倍,榨3分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于90℃的热水中浸泡,浸泡至水温为40℃时,水的用量是菊花和蝉蜕总用量的6倍,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过120目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡3小时,武火煎开,转文火煎40分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制3小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
典型病例二:林XX,男,55岁,山东省寿光市人。症状:患者长年患有高血压,14个月前出现呼吸困难的症状,睡觉时数次把自己憋醒,起初一开始以为是流行性感冒,就服用了治疗流行性感冒的药物,3天后,上述不适症状加重,去医院做了全面检查后,经医诊断为高血压性心脏病。
服用实施例2所得养生粥,每次取50g,与早晚饭同食,食用3天,明显感觉呼吸顺畅,没有了胸闷的感觉;使用15天,期间夜晚仅出现2次呼吸困难症状;继续使用10天,呼吸顺畅,夜晚没再出现过呼吸苦难的现象;患者一直食用实施例2所得养生粥,血压一直很正常。
实施例3 改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成(每份取20g):山楂12份,西红花0.8份,苦瓜粉5份,芹菜28份,玉米100份,蝉蜕7份,泽泻2份,黄连7份,当归6份,菊花4份,独活7份,大蓟8份,蜂蜜18份。
具有改善由高血压引起的心脏病功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的2倍,榨1.5分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于75℃的热水中浸泡,浸泡至水温为33℃时,水的用量是菊花和蝉蜕总用量的3倍,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过90目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡1.5小时,武火煎开,转文火煎25分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1.5小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
实施例4 改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成(每份取25g):山楂16份,西红花1.3份,苦瓜粉9份,芹菜33份,玉米150份,蝉蜕8份,泽泻4份,黄连8份,当归8份,菊花6份,独活9份,大蓟10份,蜂蜜20份。
具有改善由高血压引起的心脏病功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的4倍,榨2.5分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于85℃的热水中浸泡,浸泡至水温为38℃时,水的用量是菊花和蝉蜕总用量的5倍,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过110目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2.5小时,武火煎开,转文火煎35分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制2.5小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
典型病例三 曹XX,女,48岁,山东省青岛市崂山区。症状:患者患有高血压8年,近期出现气喘、咳嗽、呼吸困难等症状,经医院诊断为高血压性心脏病,且伴有轻度心衰现象。病龄:1年。
服用实施例4所得养生粥,每次取50g,与早晚饭同食,食用3天,头晕胸闷的症状减轻;食用10天,头晕、胸闷等不适症状消失,平卧时气急症状有所好转;继续服用10天,不适症状完全消失,使用期间无副作用。
实施例5 改善由高血压引起的心脏病的养生粥,取下述重量配比的主要原料制备而成(每份取30g):山楂14份,西红花1份,苦瓜粉7份,芹菜30份,玉米120份,蝉蜕7.5份,泽泻3份,黄连7.5份,当归7份,菊花5份,独活8份,大蓟9份,蜂蜜19份。
具有改善由高血压引起的心脏病功效的养生粥的制备方法,步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,水的用量是芹菜质量的3倍,榨2分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于80℃的热水中浸泡,浸泡至水温为35℃时,水的用量是菊花和蝉蜕总用量的4倍,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过100目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡2小时,武火煎开,转文火煎30分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制2小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
实验例 目的在于验证一下本发明养生粥对治疗高血压引起的心脏病是否具有疗效。从2012年1月到2014年1月,共200例高血压引起的心脏病患者,平均年龄为45岁。随机划分为给药组和对照组。在实验之前的一周,记录病人的身体状况,每天查看一下患者身体症状,确保给药组和对照组情况基本一致。给药组每天食用本产品实施例5所得养生粥,对照组服用其他治疗高血压引起的心脏病的药物(珍菊降压片、硝苯地平缓释片、尼群地平等常规改善由高血压引起的心脏病的药物)每天查看患者身体状况,做好记录。结果如下表1:
表1:
服用本发明养生粥在改善由高血压引起的心脏病方面,效果显著,经临床试验证明有效率为99%,治愈率为97%,本发明养生粥不仅能够改善由高血压引起的心脏病,还能增强免疫力,因此,本发明养生粥是一种疗效全面的改善由高血压引起的心脏病的食物。
Claims (8)
1.改善由高血压引起的心脏病的养生粥,其特征在于:取下述重量配比的主要原料制备而成:山楂18份,西红花1.5份,苦瓜粉10份,芹菜35份,玉米180份,蝉蜕9份,泽泻5份,黄连9份,当归9份,菊花7份,独活10份,大蓟12份,蜂蜜22份。
2.根据权利要求1所述的具有改善由高血压引起的心脏病功效的养生粥的制备方法,其特征在于:步骤如下:
(1)将芹菜去叶洗净,切成指甲盖大小的块,放入榨汁机中加水,榨1-3分钟后,取出芹菜汁待用;
(2)将菊花和蝉蜕置于70-90℃的热水中浸泡,浸泡至水温为30-40℃时,过滤,得滤液,滤液与步骤(1)所得芹菜汁混合备用;
(3)将玉米研磨成大米粒大小的块,过80-120目筛;
(4)将山楂、西红花、泽泻、黄连、当归、独活和大蓟混合,加入到步骤(2)所得混合液中浸泡1-3小时(优选浸泡2小时),武火煎开,转文火煎20-40分钟,滤出药液备用;
(5)将苦瓜粉、步骤(3)所得玉米块与步骤(4)所得药液混合,置于铁锅内,小火熬制1-3小时后加入蜂蜜,充分搅拌至蜂蜜融化后武火煎开即得养生粥。
3.根据权利要求2所述的制备方法,其特征在于:步骤(1)水的用量是芹菜质量的1-5倍(优选的,水的用量是芹菜质量的2-4倍;更加优选的,水的用量是芹菜质量的3倍)。
4.根据权利要求2所述的制备方法,其特征在于:步骤(2)水的用量是菊花和蝉蜕总用量的2-6倍(优选的,水的用量是菊花和蝉蜕总用量的3-5倍,更加优选的,水的用量是菊花和蝉蜕总用量的4倍)。
5.根据权利要求2所述的制备方法,其特征在于:步骤(2)将菊花和蝉蜕置于75-85℃的热水中浸泡(优选置于80℃的热水中浸泡)。
6.根据权利要求2所述的制备方法,其特征在于:步骤(2)浸泡至水温为33-38℃时过滤(优选浸泡至水温为35℃时过滤)。
7.根据权利要求2所述的制备方法,其特征在于:步骤(3)玉米块过90-110目筛(优选过100目筛)。
8.根据权利要求2所述的制备方法,其特征在于:步骤(5)小火熬制1.5-2.5小时后加入蜂蜜(小火熬制2小时后加入蜂蜜)。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410323669.4A CN104068319B (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥及其制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410323669.4A Division CN104068319B (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105011165A true CN105011165A (zh) | 2015-11-04 |
Family
ID=51590237
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510453513.2A Pending CN104982834A (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥的制法 |
CN201510453493.9A Pending CN105011165A (zh) | 2014-07-09 | 2014-07-09 | 一种改善由高血压引起的心脏病的养生粥 |
CN201510453335.3A Pending CN105104948A (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥 |
CN201510453492.4A Pending CN105104950A (zh) | 2014-07-09 | 2014-07-09 | 一种改善由高血压引起的心脏病的养生粥的制备工艺 |
CN201410323669.4A Expired - Fee Related CN104068319B (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510453513.2A Pending CN104982834A (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥的制法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510453335.3A Pending CN105104948A (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥 |
CN201510453492.4A Pending CN105104950A (zh) | 2014-07-09 | 2014-07-09 | 一种改善由高血压引起的心脏病的养生粥的制备工艺 |
CN201410323669.4A Expired - Fee Related CN104068319B (zh) | 2014-07-09 | 2014-07-09 | 改善由高血压引起的心脏病的养生粥及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (5) | CN104982834A (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107164189A (zh) * | 2017-06-27 | 2017-09-15 | 何秋容 | 降压保健酒的制作方法 |
CN107279707A (zh) * | 2017-08-15 | 2017-10-24 | 桐城市兴新食品有限公司 | 一种红豆杉香菇鸭肉粥及其加工工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102987217A (zh) * | 2012-10-17 | 2013-03-27 | 田欢 | 一种中年妇女养生粥 |
CN103380903A (zh) * | 2013-06-29 | 2013-11-06 | 安徽皖山食品有限公司 | 一种菊花降压膏及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007215455A (ja) * | 2006-02-15 | 2007-08-30 | National Agriculture & Food Research Organization | 低付着性で耐老化性の米飯又は米飯加工品及びその製造方法 |
CN102461883A (zh) * | 2010-11-03 | 2012-05-23 | 李玲 | 一种治疗高血压食疗配方 |
CN103055126B (zh) * | 2013-01-17 | 2014-06-18 | 张晓兰 | 一种治疗高血压性心脏病的中药组合物及其制备方法 |
-
2014
- 2014-07-09 CN CN201510453513.2A patent/CN104982834A/zh active Pending
- 2014-07-09 CN CN201510453493.9A patent/CN105011165A/zh active Pending
- 2014-07-09 CN CN201510453335.3A patent/CN105104948A/zh active Pending
- 2014-07-09 CN CN201510453492.4A patent/CN105104950A/zh active Pending
- 2014-07-09 CN CN201410323669.4A patent/CN104068319B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102987217A (zh) * | 2012-10-17 | 2013-03-27 | 田欢 | 一种中年妇女养生粥 |
CN103380903A (zh) * | 2013-06-29 | 2013-11-06 | 安徽皖山食品有限公司 | 一种菊花降压膏及其制备方法 |
Non-Patent Citations (4)
Title |
---|
常学辉: "《快乐生活一点通:生活中来的10000个小窍门》", 31 January 2014 * |
王振平 等: "植物药降压研究", 《山东教育学院学报》 * |
赵余庆 等: "《食疗与保健食品原料功能因子手册》", 31 March 2013 * |
采薇: "《活力健康蔬果汁》", 31 July 2013 * |
Also Published As
Publication number | Publication date |
---|---|
CN104068319A (zh) | 2014-10-01 |
CN104068319B (zh) | 2016-03-16 |
CN105104950A (zh) | 2015-12-02 |
CN105104948A (zh) | 2015-12-02 |
CN104982834A (zh) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN104082672B (zh) | 一种具有降血糖功效的养生粥及其制作方法 | |
CN107338150A (zh) | 一种沉香保健酒曲及其制备方法 | |
CN104068319B (zh) | 改善由高血压引起的心脏病的养生粥及其制备方法 | |
CN104304602A (zh) | 一种软化血管的槐角茶及其制备方法 | |
CN104082670B (zh) | 一种具有降血压功效的养生粥及其制作方法 | |
CN104082669B (zh) | 降低血液粘稠度的养生粥及其制备方法 | |
CN106806725A (zh) | 一种美容美白的桑葚面膜 | |
CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
CN104547432A (zh) | 治疗高血压性心脏病的中药组合物及制备方法 | |
CN108887658A (zh) | 一种治疗糖尿病的保健酱油及其制作方法 | |
CN103157003B (zh) | 一种具有保健作用的南瓜发酵药酒的制备方法、其产品及用途 | |
CN108524861A (zh) | 一种治疗失眠的中药膏及其制备方法 | |
CN105950407A (zh) | 防治脱发的保健酒及其生产方法 | |
KR20090057157A (ko) | 한약재를 이용한 오리 튀김 또는 구이와, 이의 제조 방법 | |
CN106806720A (zh) | 一种美容美白的桑葚面膜及其制备方法 | |
CN104082671B (zh) | 一种改善心脑血管疾病的养生粥及其制作方法 | |
CN105687869A (zh) | 一种缓解心力衰竭的口含片及其制备方法 | |
CN105617117A (zh) | 一种治疗混合性心绞痛的丸剂及其制备方法 | |
CN104474222A (zh) | 一种用于治疗真心痛的中药 | |
CN105360801A (zh) | 一种女贞海参肉的制备方法 | |
CN105395931A (zh) | 一种制备供冠心病患者食用的保健营养粥的方法 | |
CN104845860A (zh) | 温经补脾益肾生精柿子醋 | |
CN104738258A (zh) | 具有调节血糖功效的鲜菠菜根代茶饮及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 550000 Guizhou, Nanming District, Castle Peak Road, No. 53 Qingshan District, building 1-101, No. 2, Applicant after: Zhu Luying Address before: 250014 Ji'nan Province, Lixia District, Lixia District, No. 24 East Road, home, building, No. 2, Applicant before: Zhu Luying |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |
|
RJ01 | Rejection of invention patent application after publication |